Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 1,959 | 1,958 | 2,468 | 2,725 | 2,724 |
| Gross Profit | 1,959 | 1,958 | 2,468 | 2,725 | 2,724 |
| Operating Expenses | 2,278 | 2,401 | 4,309 | 4,380 | 2,977 |
| Operating Income | -319 | -443 | -1,841 | -1,655 | -253 |
| Other Income | 18 | 35 | 45 | 105 | 123 |
| Pre-tax Income | -301 | -408 | -1,796 | -1,550 | -130 |
| Net Income Continuous | -301 | -408 | -1,796 | -1,550 | -130 |
| Net Income | $-301 | $-408 | $-1,796 | $-1,550 | $-130 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.35 | -0.21 | 0.00 |
| EPS Basic Continuous Ops | -0.05 | -0.06 | -0.28 | -0.24 | -0.02 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.35 | -0.21 | 0.00 |
| EPS Diluted Continuous Ops | -0.05 | -0.06 | -0.28 | -0.24 | -0.02 |
| EBITDA(a) | $-319 | $-443 | $-1,841 | $-1,603 | $-218 |